You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
天壇生物(600161.SH):雲南生物製品產業化基地項目招標 國藥工程中標
格隆匯 11-27 20:48

格隆匯11月27日丨天壇生物(600161.SH)公佈,根據《中華人民共和國招標投標法》有關規定,公司下屬國藥集團上海血液製品有限公司(“上海血制”)委託招標代理機構對雲南生物製品產業化基地項目(“雲南項目”)勘察-設計-施工總承包項目(EPC)進行了公開招標,該項目經法定公開招標程序,中標候選人中國醫藥集團聯合工程有限公司(“國藥工程”)中標。

根據該項目公開招標結果,上海血制與國藥工程簽署了《國藥中生上海血制雲南生物製品產業化基地項目EPC合同》,合同總金額為中標價格約6.30億元。

國藥工程與公司受同一實際控制人中國醫藥集團有限公司(“國藥集團”)控制,根據《上海證券交易所股票上市規則》和《上海證券交易所上市公司關聯交易實施指引》的規定,上述交易構成關聯交易。此次關聯交易不構成《上市公司重大資產重組管理辦法》規定的重大資產重組。

關聯交易通過公開招標形成不會損害公司和其他股東的利益,其實施完成將有利於加快推動上海血制雲南項目建設,從而儘快實現通過擴大產能和入新工藝步提升企業競爭力,搶佔市場份額公司對交易涉及的關聯方不存依賴,上述關聯交易不會影響上市公司的獨立性。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account